These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12555357)

  • 61. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 62. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
    Christin F; Theissen-Laval O; Loeb JP
    Ann Fr Anesth Reanim; 1998; 17(1):82-3. PubMed ID: 9750692
    [No Abstract]   [Full Text] [Related]  

  • 63. Heparin induced thrombocytopenia: diagnosis and management update.
    Ahmed I; Majeed A; Powell R
    Postgrad Med J; 2007 Sep; 83(983):575-82. PubMed ID: 17823223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
    Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
    Woo YL; Allard S; Cohen H; Letsky E; de Swiet M
    BJOG; 2002 Apr; 109(4):466-8. PubMed ID: 12013171
    [No Abstract]   [Full Text] [Related]  

  • 66. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
    Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
    Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heparin-induced thrombocytopenia and thrombosis: a potential fatal complication in a routine treatment.
    Boon DM; Kappers-Klunne MC; Michiels JJ; Stibbe J; van Vliet HH
    Neth J Med; 1995 Mar; 46(3):146-52. PubMed ID: 7731489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.
    O'Connor ED; Fraser JF
    Crit Care Resusc; 2006 Dec; 8(4):345-52. PubMed ID: 17227274
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.
    Koster A; Meyer O; Hausmann H; Kuppe H; Hetzer R; Mertzlufft F
    J Clin Anesth; 2000 Jun; 12(4):324-7. PubMed ID: 10960207
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 1999 Jun; 7(3):259-64. PubMed ID: 10375387
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
    Cooney MF
    Crit Care Nurse; 2006 Dec; 26(6):30-6; quiz 37. PubMed ID: 17123949
    [No Abstract]   [Full Text] [Related]  

  • 72. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
    Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
    Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
    [TBL] [Abstract][Full Text] [Related]  

  • 73. White Clot Syndrome.
    Mallios A; Jennings W
    Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):404. PubMed ID: 29054794
    [No Abstract]   [Full Text] [Related]  

  • 74. Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting.
    Baciewicz FA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2108-9; author reply 2109. PubMed ID: 14688746
    [No Abstract]   [Full Text] [Related]  

  • 75. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
    Wilhelm MJ; Schmid C; Kececioglu D; Möllhoff T; Ostermann H; Scheld HH
    Ann Thorac Surg; 1996 Mar; 61(3):920-4. PubMed ID: 8619718
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
    Tardy/Poncet B; Mahul P; Beraud AM; Favre JP; Tardy B; Guyotat D
    Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684
    [No Abstract]   [Full Text] [Related]  

  • 77. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
    Shantsila E; Lip GYH; Chong BH
    Chest; 2009 Jun; 135(6):1651-1664. PubMed ID: 19497901
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
    Neuhaus TJ; Goetschel P; Schmugge M; Leumann E
    Pediatr Nephrol; 2000 Aug; 14(8-9):713-6. PubMed ID: 10955913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Headaches in a 21-year-old man with Goodpasture disease].
    Petit JS; Murat O; Perrier S; Lepouse C; Jaussaud M; Léon A
    Ann Fr Anesth Reanim; 2009 Sep; 28(9):799-802. PubMed ID: 19682834
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia.
    Faratro R; D'Gama C; Chan C
    CANNT J; 2008; 18(4):32-5. PubMed ID: 19175190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.